Community-Acquired Pneumonia | Usefulness of Microbiological Tests in Community-Acquired Pneumonia
Community-Acquired Pneumonia research study
What is the primary objective of this study?
The hypothesis is that community-acquired pneumonia is usually a monomicrobial infection. Therefore, early detection of the etiology allows to select the most active, narrow-spectrum, and cheap, and less toxic antibiotic agent.
Who is eligible to participate?
Inclusion Criteria: - Age: 18 years and above - Clinical and radiological diagnosis of community-acquired pneumonia - Informed consent of patient - Hospital admission Exclusion Criteria: - Prior hospital admission (less than 15 days) - Alternative diagnosis at the discharge - Immunosuppression (HIV infection, immunosuppressive therapies, neutropenia) - Risk factors for unusual etiologies - Patient is pregnant
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Procedure:empirical versus microbiological guided treatment
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
Start Date: April 2006
Completed Date: May 2008
Primary Outcome: Clinical and economic consequences obtained with the antibiotic selection in basis to early mcrobiological results
Secondary Outcome: Importance of polimicrobial etiology in community-acquired pneumonia
Study sponsors, principal investigator, and references
Principal Investigator: Miquel Falguera, M.D.
Lead Sponsor: Hospital Arnau de Vilanova